Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP000485

Drug Information
NameOxprenolol
Synonymsoxprenolol; 1-(propan-2-ylamino)-3-(2-prop-2-enoxyphenoxy)propan-2-ol; 1-[(1-Methylethyl)amino]-3-[2-(2-propenyloxy)phenoxy]-2-propanol; Slow-Pren (*hydrochloride*); (1)-1-(o-(Allyloxy)phenoxy)-3-(isopropylamino)propan-2-ol; Coretal; BRD-A43671941-003-03-6; dl-Alprenolol; DB01580; 1-((1-Methylethyl)amino)-3-(2-(2-propenyloxy)phenoxy)-2-propanol; 1-(Isopropylamino)-2-hydroxy-3-(o-(allyloxy)phenoxy)propane; Trasacor (*hydrochloride*); Trasacor; L013416; Laracor; Osprenololo; Trasicor; Oxprenolol (TN); (+-)-Oxprenolol; Slow-pren; Slow Trasicor; Osprenololo [DCIT]; Prestwick3_001057; AC1L1ILM; 2-Propanol, 1-(2-allyloxyphenoxy)-3-(isopropylamino)-; SPBio_002937; CID4631; AB00514712; Trasicor (*hydrochloride*); BPBio1_001116; LS-121642; UNII-519MXN9YZR; BSPBio_001014; Prestwick1_001057; 2-Propanol, 1-((1-methylethyl)amino)-3-(2-(2-propenyloxy)phenoxy)-; EINECS 229-257-9; Oxprenolol Ba 39089 (*hydrochloride*); 22972-96-9; Koretal; Oxprenolol [INN:BAN]; CHEMBL546; Trasicor 80; 71186-75-9; dl-Oxprenolol; 22972-98-1; (+)-1-(o-(Allyloxy)phenoxy)-3-(isopropylamino)propan-2-ol; C15H23NO3; Laracor (*hydrochloride*); Tevacor; Oxprenolol, dl-; 6452-71-7; EINECS 245-359-6; CCRIS 4201; EINECS 245-357-5; Oxprenololum [INN-Latin]; 1-[2-(Allyloxy)phenoxy]-3-(isopropylamino)-2-propanol; Oxprenolol (INN); 6452-73-9 (HYDROCHLORIDE); Coretal (*hydrochloride*); Prestwick0_001057; Oxprenololum; 1-(o-(Allyloxy)phenoxy)-3-(isopropylamino)-2-propanol; CHEBI:113756; 2-Propanol, 1-[(1-methylethyl)amino]-3-[2-(2-propenyloxy)phenoxy]-; Prestwick2_001057; D08318; 2-Propanol, 1-[(1-methylethyl)amino]-3-[2-(2-propenyloxy)phenoxy]-, (+/-)
Trade NameTrasacor; Trasicor; Coretal; Laracor; Slow-Pren; Captol; Corbeton; Slow-Trasicor; Tevacor; Trasitensin; Trasidex
IndicationHypertension
[ICD9: 401   ICD10: I10, I11, I12, I13, I15]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C15H23NO3/c1-4-9-18-14-7-5-6-8-15(14)19-11-13(17)10-16-12(2)3/
h4-8,12-13,16-17H,1,9-11H2,2-3H3
InChIKeyCEMAWMOMDPGJMB-UHFFFAOYSA-N
Canonical SMILESCC(C)NCC(COC1=CC=CC=C1OCC=C)O    
Therapeutic ClassAntihypertensive Agents
CAS NumberCAS 6452-71-7
FormulaC15H23NO3
PubChem Compound IDCID 4631.
PubChem Substance IDSID 165537.
SuperDrug ATC IDC07AA02
SuperDrug CAS ID006452717;
TargetBeta-1 adrenergic receptorAntagonist[2]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 018166 To Reference
Ref 2Prediction and experimental validation of acute toxicity of beta-blockers in Ceriodaphnia dubia. Environ Toxicol Chem. 2005 Oct;24(10):2470-6. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543